Soligenix
SNGX
#10288
Rank
A$15.65 M
Marketcap
A$1.55
Share price
-0.90%
Change (1 day)
-57.92%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$13.2 Million a decrease over its 2023 earnings that were of -A$10.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million46.91%
2024 -A$13.2 Million22.96%
2023 -A$10.73 Million-45.74%
2022 -A$19.78 Million11.88%
2021 -A$17.68 Million-32.37%
2020 -A$26.13 Million83.18%
2019 -A$14.27 Million11.57%
2018 -A$12.79 Million19.29%
2017 -A$10.72 Million33%
2016 -A$8.06 Million-19.7%
2015 -A$10.04 Million5.16%
2014 -A$9.55 Million
2010 -A$10.77 Million26.12%
2009 -A$8.54 Million75.1%
2008 -A$4.88 Million-45.38%
2007 -A$8.93 Million-22.84%
2006 -A$11.58 Million66.15%
2005 -A$6.97 Million-16.65%
2004 -A$8.36 Million13.28%
2003 -A$7.38 Million-11.88%
2002 -A$8.38 Million-59.44%
2001 -A$20.64 Million378.18%
2000 -A$4.32 Million-38.53%
1999 -A$7.03 Million-18.43%
1998 -A$8.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.71 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.72 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.84 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.63 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$58.94 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.03 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.89 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA